Agilon Health, Inc.
AGL · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 5, 2026 | — | 1.45B | — | 0.06 | — |
| 2026 Q1 | May 6, 2026 | 1.42B | 1.38B | 2.94 | 1.13 | +117.81% |
| 2025 Q4 | February 25, 2026 | 1.57B | 1.47B | -0.46 | -6.70 | +18.92% |
| 2025 Q3 | November 4, 2025 | 1.44B | 1.42B | -6.75 | -4.40 | +4.05% |
| 2025 Q2 | August 4, 2025 | 1.39B | 1.47B | -6.25 | -2.68 | +1.12% |
| 2025 Q1 | May 6, 2025 | 1.53B | 1.50B | 0.03 | -0.13 | -23.99% |
| 2024 Q4 | February 25, 2025 | 1.52B | 1.52B | -6.25 | -5.53 | -7.44% |
| 2024 Q3 | November 7, 2024 | 1.45B | 1.47B | -7.25 | -2.53 | -34.05% |
| 2024 Q2 | August 6, 2024 | 1.48B | 1.54B | -1.75 | -1.75 | -9.32% |
| 2024 Q1 | May 7, 2024 | 1.60B | 1.61B | 0.25 | -0.43 | +4.22% |
| 2023 Q4 | February 27, 2024 | 1.06B | 1.04B | -10.25 | -6.90 | -1.85% |
| 2023 Q3 | November 2, 2023 | 1.22B | 1.13B | -1.50 | -1.28 | -13.20% |
| 2023 Q2 | August 3, 2023 | 1.15B | 1.11B | -1.00 | -0.43 | +2.15% |
| 2023 Q1 | May 9, 2023 | 1.14B | 1.08B | 1.00 | 0.75 | -3.92% |
| 2022 Q4 | March 1, 2023 | 689.77M | 662.01M | -3.50 | -1.95 | +16.03% |
| 2022 Q3 | November 3, 2022 | 695.00M | 662.21M | -1.75 | -1.18 | -10.31% |